BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25444604)

  • 1. Integrated cortical structural marker for Alzheimer's disease.
    Ming J; Harms MP; Morris JC; Beg MF; Wang L
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S53-9. PubMed ID: 25444604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited relationships between two-year changes in sulcal morphology and other common neuroimaging indices in the elderly.
    Liu T; Sachdev PS; Lipnicki DM; Jiang J; Geng G; Zhu W; Reppermund S; Tao D; Trollor JN; Brodaty H; Wen W
    Neuroimage; 2013 Dec; 83():12-7. PubMed ID: 23800792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulcal morphology changes and their relationship with cortical thickness and gyral white matter volume in mild cognitive impairment and Alzheimer's disease.
    Im K; Lee JM; Seo SW; Hyung Kim S; Kim SI; Na DL
    Neuroimage; 2008 Oct; 43(1):103-13. PubMed ID: 18691657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
    Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease.
    Cantero JL; Atienza M; Sanchez-Juan P; Rodriguez-Rodriguez E; Vazquez-Higuera JL; Pozueta A; Gonzalez-Suarez A; Vilaplana E; Pegueroles J; Montal V; Blesa R; Alcolea D; Lleo A; Fortea J
    Neurobiol Aging; 2018 Apr; 64():58-67. PubMed ID: 29331877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.
    Eskildsen SF; Coupé P; Fonov VS; Pruessner JC; Collins DL;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S23-31. PubMed ID: 25260851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas.
    Thompson PM; Mega MS; Woods RP; Zoumalan CI; Lindshield CJ; Blanton RE; Moussai J; Holmes CJ; Cummings JL; Toga AW
    Cereb Cortex; 2001 Jan; 11(1):1-16. PubMed ID: 11113031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices.
    Cai K; Xu H; Guan H; Zhu W; Jiang J; Cui Y; Zhang J; Liu T; Wen W
    PLoS One; 2017; 12(1):e0170875. PubMed ID: 28129351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous changes in gray matter volume and white matter fractional anisotropy in Alzheimer's disease revealed by multimodal CCA and joint ICA.
    Ouyang X; Chen K; Yao L; Hu B; Wu X; Ye Q; Guo X;
    Neuroscience; 2015 Aug; 301():553-62. PubMed ID: 26116521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping ventricular expansion onto cortical gray matter in older adults.
    Madsen SK; Gutman BA; Joshi SH; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S32-41. PubMed ID: 25311280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining anatomical, diffusion, and resting state functional magnetic resonance imaging for individual classification of mild and moderate Alzheimer's disease.
    Schouten TM; Koini M; de Vos F; Seiler S; van der Grond J; Lechner A; Hafkemeijer A; Möller C; Schmidt R; de Rooij M; Rombouts SARB
    Neuroimage Clin; 2016; 11():46-51. PubMed ID: 26909327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of structural brain MRI and multi-parameter classification for Alzheimer's disease.
    Zhang Y; Liu S
    Biomed Tech (Berl); 2018 Jul; 63(4):427-437. PubMed ID: 28622141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of regional gray matter atrophy, white matter alteration, and glucose metabolism as a predictor of the conversion to Alzheimer's disease in mild cognitive impairment.
    Sohn BK; Yi D; Seo EH; Choe YM; Kim JW; Kim SG; Choi HJ; Byun MS; Jhoo JH; Woo JI; Lee DY
    J Korean Med Sci; 2015 Jun; 30(6):779-87. PubMed ID: 26028932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.
    Madsen SK; Rajagopalan P; Joshi SH; Toga AW; Thompson PM;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S203-10. PubMed ID: 25444607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease.
    Acosta O; Fripp J; Doré V; Bourgeat P; Favreau JM; Chételat G; Rueda A; Villemagne VL; Szoeke C; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Bonner E; Gris F; Xiao D; Raniga P; Barra V; Salvado O
    J Neurosci Methods; 2012 Mar; 205(1):96-109. PubMed ID: 22226742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimensionality reduced cortical features and their use in predicting longitudinal changes in Alzheimer's disease.
    Park H; Yang JJ; Seo J; Lee JM;
    Neurosci Lett; 2013 Aug; 550():17-22. PubMed ID: 23827219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Callosal thickness profiles for prognosticating conversion from mild cognitive impairment to Alzheimer's disease: A classification approach.
    Adamson C; Beare R; Ball G; Walterfang M; Seal M;
    Brain Behav; 2018 Dec; 8(12):e01142. PubMed ID: 30565884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.